Managed Care Aspects of Managing Neurogenic Bladder/Neurogenic Detrusor Overactivity

This activity is supported by an educational grant from Allergan, Inc.

An Online E-Newsletter

William J. Cardarelli, PharmD

Director of Pharmacy Revenue and SupplyAtrius HealthHarvard Vanguard Medical AssociatesWatertown, Massachusetts

Contributing Editorial Support

Elizabeth Paczolt, MD, FACNM

Medical ConsultantChurchville, Pennsylvania

Activity Overview

Neurogenic bladder (NGB) is a complex, highly prevalent disorder that is associated with numerous complications and considerable costs to the US health care system and society. Unfortunately, despite its detrimental impact on patient quality of life and its undeniable burden, the disease continues to be under-recognized, underdiagnosed, and undermanaged. In an effort to guide best clinical practices and optimal treatment strategies for NGB, Part 3 of this newsletter series carefully examines the patient-related implications, clinical burden, and health care utilization tied to NGB.

Intended Audience

Medical directors, pharmacy directors, specialty pharmacists, and other managed care professionals who oversee the treatment of patients with neurogenic bladder.

Educational Objectives

Upon completion of this educational activity, the participant should be able to:

• Examine the impact of neurogenic bladder (NGB) on patient health and quality of life.
• Identify the extent of health care utilization associated with NGB and the consequences of disease
• Discuss the economic burden and implications of NGB

Release date: April 18, 2014

Expiration date: April 18, 2015

Estimated time to complete activity: 1.0 hours

Type of activity: Knowledge

Medium: Internet-based activity with polling questions, evaluation, and request for credit

Physician Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Cincinnati and Pharmacy Times Office of Continuing Professional Education. The University of Cincinnati is accredited by the

ACCME to provide continuing medical education for physicians.

Credit Designation

The University of Cincinnati designates this online activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Credit

Accreditation and Credit Designation

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEUs) under the ACPE universal activity number 0290-9999-14-034-H01-P. The activity is available for CE credit through April 18, 2015.

Obtaining Credit: Participants must read the entire online e-Newsletter, take the pretest and posttest (achieving a passing score of 70% or higher), and complete the online evaluation. Once the activity evaluation has been submitted, participants can request their statement of credit.

For Physician credit (CME) only

Physicians Only

Start Activity

For Pharmacy credit (CPE) only

Pharmacists Only

Start Activity